Supplementary Prognostic Variables for Pleural Mesothelioma A Report from the IASLC Staging Committee

Creative Commons License

Pass H. I., Giroux D., Kennedy C., Ruffini E., KAYI CANGIR A., Rice D., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.9, no.6, pp.856-864, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 6
  • Publication Date: 2014
  • Doi Number: 10.1097/jto.0000000000000181
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.856-864
  • Keywords: Mesothelioma, Surgery, Prognosis, Registry, Staging, TO-LYMPHOCYTE RATIO, PHASE-II TRIALS, MALIGNANT MESOTHELIOMA, EXTRAPLEURAL PNEUMONECTOMY, INTERNATIONAL-ASSOCIATION, LUNG-CANCER, SURVIVAL, VALIDATION, EXPRESSION, VOLUME
  • Ankara University Affiliated: Yes

Abstract

Introduction: The staging system for malignant pleural mesothelioma is controversial. To revise this system, the International Association for the Study of Lung Cancer Staging Committee developed an international database. This report analyzes prognostic variables in a surgical population, which are supplementary to previously published CORE variables (stage, histology, sex, age, and type of procedure).